Research Article
[Retracted] Predictive Value of Perioperative Cytokine Levels on the Risk for In-Stent Restenosis in Acute Myocardial Infarction Patients
Table 1
Comparison of clinical data of patients ((
±
s) (
n, %)).
| | Clinical data | Restenosis group (n = 44) | Nonrestenosis group (n = 405) | t/χ2 | value |
| | Sex (n, %) | | | 0.6921) | 0.405 | | Male | 25 (56.82) | 256 (63.21) | | | | Female | 19 (43.18) | 149 (36.79) | | | | Age (year) | 52.98 ± 8.26 | 51.61 ± 9.01 | 1.0352) | 0.305 | | BMI (kg/m2) | 22.88 ± 1.24 | 22.85 ± 1.37 | 0.1512) | 0.881 | | Family history of acute myocardial infarction (n, %) | 14 (31.82) | 123 (30.37) | 0.0391) | 0.843 | | Smoking history (n, %) | 25 (56.82) | 186 (45.68) | 1.9781) | 0.160 |
| | Combined diseases (n, %) | | | | | | Hypertension | 11 (25.00) | 105 (25.93) | 0.0181) | 0.894 | | Diabetes | 12 (27.27) | 103 (25.43) | 0.0711) | 0.791 | | Hyperlipidemia | 20 (45.45) | 144 (35.56) | 1.6781) | 0.196 |
| | Coronary intervention | | | | | | Number of lesions (n, %) | | | 1.5521) | 0.213 | | Single vessel lesion | 35 (79.55) | 286 (70.62) | | | | Double vessel/multi-vessel lesions | 9 (20.45) | 119 (29.38) | | | | Target vessel stent length (mm) | 18.24 ± 2.98 | 18.38 ± 3.01 | 0.2962) | 0.769 | | Target vessel stent diameter (mm) | 3.42 ± 0.53 | 3.32 ± 0.61 | 1.1702) | 0.247 | | Target vessel stent location (n, %) | | | 0.9231) | 0.630 | | Anterior descending branch | 26 (59.09) | 214 (52.84) | | | | Circumflex branch | 13 (29.55) | 125 (30.86) | | | | Right coronary artery | 5 (11.36) | 66 (16.30) | | |
| | Out-of-hospital medication (n, %) | | | | | | β receptor blocker | 35 (79.55) | 286 (70.62) | 1.5521) | 0.213 | | ACEI/ARB | 30 (68.18) | 235 (58.02) | 1.6931) | 0.193 | | Dual antiplatelet therapy | 34 (77.28) | 268 (66.17) | 2.2211) | 0.136 | | Others | 26 (59.09) | 223 (55.06) | 0.2611) | 0.610 |
|
|
1)χ2 test; 2)independent sample t-test.
|
